These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22939387)

  • 1. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
    Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ
    Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
    Maxwell PJ; Neisen J; Messenger J; Waugh DJ
    Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.
    Maxwell PJ; Gallagher R; Seaton A; Wilson C; Scullin P; Pettigrew J; Stratford IJ; Williams KJ; Johnston PG; Waugh DJ
    Oncogene; 2007 Nov; 26(52):7333-45. PubMed ID: 17533374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL8, an underestimated "bad guy" in prostate cancer.
    Culig Z
    Eur Urol; 2013 Aug; 64(2):189-90; discussion 190-2. PubMed ID: 23000087
    [No Abstract]   [Full Text] [Related]  

  • 5. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway.
    Li MQ; Luo XZ; Meng YH; Mei J; Zhu XY; Jin LP; Li DJ
    Hum Reprod; 2012 Jul; 27(7):2107-16. PubMed ID: 22563025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.
    Wilson C; Maxwell PJ; Longley DB; Wilson RH; Johnston PG; Waugh DJ
    PLoS One; 2012; 7(5):e36545. PubMed ID: 22590561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL8-CXCR1/2 pathways in cancer.
    Liu Q; Li A; Tian Y; Wu JD; Liu Y; Li T; Chen Y; Han X; Wu K
    Cytokine Growth Factor Rev; 2016 Oct; 31():61-71. PubMed ID: 27578214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
    Furgeson SB; Simpson PA; Park I; Vanputten V; Horita H; Kontos CD; Nemenoff RA; Weiser-Evans MC
    Cardiovasc Res; 2010 May; 86(2):274-82. PubMed ID: 20051384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.
    Wilson C; Purcell C; Seaton A; Oladipo O; Maxwell PJ; O'Sullivan JM; Wilson RH; Johnston PG; Waugh DJ
    J Pharmacol Exp Ther; 2008 Dec; 327(3):746-59. PubMed ID: 18780829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
    Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
    Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
    Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
    Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.
    Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM; Webster SJ; Flower D; Woll PJ
    Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of IL-8 receptors in cultured guinea pig Müller glial cells is modified by signals from retinal pigment epithelium.
    Malgorzata Goczalik I; Raap M; Weick M; Milenkovic I; Heidmann J; Enzmann V; Wiedemann P; Reichenbach A; Francke M
    J Neuroimmunol; 2005 Apr; 161(1-2):49-60. PubMed ID: 15748943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
    Lo MC; Yip TC; Ngan KC; Cheng WW; Law CK; Chan PS; Chan KC; Wong CK; Wong RN; Lo KW; Ng WT; Lee WM; Tsao SW; Kwong LW; Lung ML; Mak NK
    Cancer Lett; 2013 Jul; 335(1):81-92. PubMed ID: 23403077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
    Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
    Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL8 gene silencing promotes neuroglial cells activation while inhibiting neuroinflammation through the PI3K/Akt/NF-κB-signaling pathway in mice with ischemic stroke.
    Lv H; Li J; Che YQ
    J Cell Physiol; 2019 May; 234(5):7341-7355. PubMed ID: 30362547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
    Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
    J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.
    Singh S; Wu S; Varney M; Singh AP; Singh RK
    Microvasc Res; 2011 Nov; 82(3):318-25. PubMed ID: 21749879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.